{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-039048","form_type":"8-K","ticker":"MNKD","cik":"0000899460","company_name":"MANNKIND CORP","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.967916+00:00","generated_at":"2026-06-12T05:26:04.733388+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MannKind Q2 total revenues $49M (+157% YoY); Tyvaso DPI royalties $19M (+63% QoQ)","bullets":["Tyvaso DPI royalties $19M in Q2, up 63% from Q1, driven by strong patient demand.","Afrezza net revenue $13.5M, up 27% YoY due to higher demand and price.","GAAP income from operations $2M; non-GAAP income from operations $8M.","Total revenues H1 2023 $89.2M, +189% vs H1 2022.","Cash and investments $146.6M as of June 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-039048","json":"https://secwatch.observer/filing/0000950170-23-039048.json","markdown":"https://secwatch.observer/filing/0000950170-23-039048.md","text":"https://secwatch.observer/filing/0000950170-23-039048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899460/000095017023039048/0000950170-23-039048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899460/000095017023039048/mnkd-20230807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:26:04.733388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba90527566d39c3ee9738b032698cdec4485b76f","claim":"MANNKIND CORP reported quarter ended June 30, 2023 results: revenue $48,611.","evidence_excerpt":"27 % Net revenue – V-Go 4,818 2,073 $ 2,745 * Revenue – collaborations and services 11,211 5,868 $ 5,343 91 % Royalties – collaborations 19,055 304 $ 18,751 * Total revenues $ 48,611 $ 18,894 $ 29,717 157 % ________________________ * Not meaningful Afrezza net revenue for the second quarter of 2023 increased $2.9 million, or 27%, compared to the same period in","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/899460/000095017023039048/0000950170-23-039048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended June 30, 2023"},{"label":"Revenue","value":"$48,611"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}